ACE inhibitors

Mar 27, 2020

Lisinopril Market Study 2020: Global Trends & Developments, Major Players, Patents, and More

Sep 02, 2019

Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings

Jun 25, 2019

Global Angiotensin Converting Enzymes (ACE) Inhibitors Market to Surpass US$ 12.4 Billion by 2026

Nov 11, 2018

New Novartis study supports Entresto as foundational HFrEF therapy and in-hospital initiation in appropriate stabilized heart failure patients

Jul 04, 2018

Pharmascience Inc. launches (Pr)pms-TRANDOLAPRIL, first generic bioequivalent to (Pr)MAVIK® available on the market, for the treatment of mild to moderate essential hypertension

May 28, 2018

Patient-reported outcomes tool revealed significant improvement in symptom frequency and quality of life domains with Entresto®

Nov 15, 2017

Noden Pharma Announces FDA Approval of Tekturna®(aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older

Sep 19, 2017

New analysis shows Entresto improved physical and social activity in patients with HFrEF